BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22843128)

  • 21. The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancer.
    Vivat B; Young TE; Winstanley J; Arraras JI; Black K; Boyle F; Bredart A; Costantini A; Guo J; Irarrazaval ME; Kobayashi K; Kruizinga R; Navarro M; Omidvari S; Rohde GE; Serpentini S; Spry N; Van Laarhoven HWM; Yang GM;
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28776784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.
    Oberguggenberger AS; Nagele E; Inwald EC; Tomaszewski K; Lanceley A; Nordin A; Creutzberg CL; Kuljanic K; Kardamakis D; Schmalz C; Arraras J; Costantini A; Almont T; Wei-Chu C; Dehandschutter S; Winters Z; Greimel E;
    Cancer Med; 2018 Mar; 7(3):635-645. PubMed ID: 29436144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
    Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
    Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
    Davies AH; Larsson G; Ardill J; Friend E; Jones L; Falconi M; Bettini R; Koller M; Sezer O; Fleissner C; Taal B; Blazeby JM; Ramage JK;
    Eur J Cancer; 2006 Mar; 42(4):477-84. PubMed ID: 16412628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries.
    Arraras JI; Wintner LM; Sztankay M; Tomaszewski KA; Hofmeister D; Costantini A; Bredart A; Young T; Kuljanic K; Tomaszewska IM; Kontogianni M; Chie WC; Kulis D; Greimel E;
    Support Care Cancer; 2017 May; 25(5):1485-1494. PubMed ID: 28025709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
    Morita S; Kaptein AA; Oba K; Sakamoto J
    Psychooncology; 2008 May; 17(5):474-9. PubMed ID: 17847126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries.
    Arraras JI; Kuljanic-Vlasic K; Bjordal K; Yun YH; Efficace F; Holzner B; Mills J; Greimel E; Krauss O; Velikova G;
    Psychooncology; 2007 Mar; 16(3):249-54. PubMed ID: 16858744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a questionnaire to evaluate the information needs of cancer patients: the EORTC questionnaire.
    Arraras JI; Wright S; Greimel E; Holzner B; Kuljanic-Vlasic K; Velikova G; Eisemann M; Visser A;
    Patient Educ Couns; 2004 Aug; 54(2):235-41. PubMed ID: 15288920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT).
    Gamper EM; Petersen MA; Aaronson N; Costantini A; Giesinger JM; Holzner B; Kemmler G; Oberguggenberger A; Singer S; Young T; Groenvold M;
    Health Qual Life Outcomes; 2016 May; 14():72. PubMed ID: 27150974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.
    Sodergren SC; Johnson CD; Gilbert A; Tomaszewski KA; Chu W; Chung HT; Dennis K; Desideri I; Glynne-Jones R; Grønlie Guren M; Kardamakis D; Nugent K; Schmidt H; Sebag-Montefiore D; Vassiliou V;
    Radiother Oncol; 2018 Feb; 126(2):222-228. PubMed ID: 29217122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
    Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in head and neck cancer patients after surgical resection: translation into Cantonese and validation of the EORTC QLQ-H&N35.
    Bower WF; Vlantis AC; Chung TM; Cheung SK; Bjordal K; van Hasselt CA
    Acta Otolaryngol; 2009 Jul; 129(7):779-85. PubMed ID: 18767001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC)].
    Singer S; Hofmeister D; Spiegel K; Boehm A
    Laryngorhinootologie; 2011 Oct; 90(10):591-4. PubMed ID: 22016255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.